CLCR Call: March 21, 2022

For Public Health

At a glance

The March 21, 2022, Clinical Laboratory COVID-19 Response (CLCR) call included antigen testing guidance update, HHS reporting requirements update, and SARS-CoV-2 testing using rapid antigen tests key findings, as well as updates from FDA.

Format: MP3
Language: English (US)
Size: 42 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

Antigen Testing Guidance Update: Reynolds (Ren) Salerno, CDC Division of Laboratory Systems (DLS)

HHS Reporting Requirements Update: Jason Hall, CDC Data, Analytics, and Visualization Task Force

Key Findings for SARS-CoV-2 Testing Using Rapid Antigen Tests from RADx Clinical Studies Core: Apurv Soni, University of Massachusetts Chan Medical School

FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)

Meeting materials

Content Source
About this page
Published: November 20, 2024
Updated: March 21, 2022

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: March 21, 2022

The information on this page was last reviewed by subject matter experts to ensure accuracy.